StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Petros Pharmaceuticals's total assets was $3.55M at Jun 30, 2026. For fiscal 2025 it was $5.16M, down 51.4% from the year before. The highest annual figure on record is $69.85M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.16M-51.4%
FY2024Dec 31, 2024$10.64M-68.5%
FY2023Dec 31, 2023$33.80M+4.2%
FY2022Dec 31, 2022$32.42M-51.9%
FY2021Dec 31, 2021$67.39M-3.5%
FY2020Dec 31, 2020$69.85M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.55M-52.1%
Q1 FY2026Mar 31, 2026$4.39M-75.0%
Q4 FY2025Dec 31, 2025$5.16M-51.4%
Q3 FY2025Sep 30, 2025$6.13M-70.4%
Q2 FY2025Jun 30, 2025$7.40M-70.6%
Q1 FY2025Mar 31, 2025$17.61M-41.9%
Q4 FY2024Dec 31, 2024$10.64M-68.5%
Q3 FY2024Sep 30, 2024$20.69M-46.8%
Q2 FY2024Jun 30, 2024$25.17M-12.4%
Q1 FY2024Mar 31, 2024$30.31M-0.8%
Q4 FY2023Dec 31, 2023$33.80M+4.2%
Q3 FY2023Sep 30, 2023$38.91M+3.2%
Q2 FY2023Jun 30, 2023$28.73M-43.7%
Q1 FY2023Mar 31, 2023$30.57M-45.3%
Q4 FY2022Dec 31, 2022$32.42M-51.9%
Q3 FY2022Sep 30, 2022$37.70M-33.5%
Q2 FY2022Jun 30, 2022$51.05M-22.8%
Q1 FY2022Mar 31, 2022$55.86M-20.0%
Q4 FY2021Dec 31, 2021$67.39M–
Q2 FY2021Jun 30, 2021$56.67M–
Q1 FY2021Mar 31, 2021$66.15M–
Q4 FY2020Dec 31, 2020$69.85M–

More Petros Pharmaceuticals figures

See a number that looks wrong?